波音游戏-波音娱乐城赌球打不开

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


赌百家乐官网澳门| 百家乐官网建材| 澳门玩百家乐官网赢1000万| 防伪百家乐官网筹码币套装| 鑫鼎百家乐的玩法技巧和规则| 百家乐五湖四海娱乐网| 大发888娱乐城.com| bet365 uo15| 百家乐官网高返水| 真人在线百家乐| 威尼斯人娱乐城客户端| 澳门百家乐官网指数| 在线赌博网| 免费百家乐官网分析工具| 乐天堂百家乐娱乐场| 金赞娱乐城| 百家乐官网电脑赌博| 大发888娱乐场17| 百家乐棋牌官网| 大发888娱乐城出纳| 博九最新网址| 百家乐官网家居 | 大发888娱乐游戏注册| 太阳城百家乐杀猪吗| 犹太人百家乐官网的玩法技巧和规则 | 百家乐官网棋牌辅助| 运城百家乐的玩法技巧和规则 | 至尊百家乐节目单| 网上百家乐是叫九五至尊么| 德州百家乐扑克桌| 百家乐二路珠无敌稳赢打法| 百家乐视频下载| 百家乐策略介绍| 澳门百家乐官网战法| 罗盘24山八卦| 正品百家乐电话| 百家乐官网客户端皇冠| 皇冠百家乐代理网址| 百家乐官网证据| 真人赌博网站| 百家乐筹码价格|